4/5/2011

The FDA granted marketing approval for Mylan's generic version of Xalatan, an eye drop from Pharmacia and Upjohn that reduces pressure. The copy, latanoprost, is Mylan's first ophthalmic solution, said President Heather Bresch.

Related Summaries